Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Tappahannock › NPI 1760580757
Hospital

Vcu Health Tappahannock Hospital

Vcu Health Tappahannock Hospital was paid $20.60M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.

33Billing provider infoVCU HEALTH TAPPAHANNOCK HOSPITAL
TAPPAHANNOCK, VA 22560
33aNPI1760580757assigned 09/21/2006
28Total paid$20.60M
24GClaims450,951
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Virginia

Rank by total paid#4 of 6
Median peer was paid$20.60M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201843,447$1.07M
201964,991$1.86M
202057,999$1.91M
202169,932$2.17M
202272,523$3.60M
202378,035$6.00M
2024incomplete64,024$4.00M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 22,216 18,932 $4.32M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 18,210 14,821 $3.35M
96361 Intravenous infusion, hydration; each additional hour 13% 8,103 5,877 $2.64M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 9,051 7,407 $2.23M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.9% 4,026 3,426 $1.00M
70450 Computed tomography, head or brain; without contrast material 4.3% 3,977 3,372 $883K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.1% 5,876 4,085 $637K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.5% 3,321 2,993 $514K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2.3% 1,737 1,186 $475K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.0% 2,242 1,862 $418K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.7% 1,476 1,356 $347K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 870 778 $346K
194 more codes
G0378 Hospital observation service, per hour 1.7% 1,262 $342K
71275 Computed tomographic angiography, chest, with contrast material 1.6% 1,060 $324K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.4% 5,381 $282K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 2,031 $230K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,148 $166K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,381 $158K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,935 $119K
96375 Therapeutic injection; each additional sequential IV push <1% 8,672 $115K
97161 <1% 666 $108K
80053 Comprehensive metabolic panel <1% 22,775 $107K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,092 $102K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,420 $93K
71046 Radiologic examination, chest; 2 views <1% 6,862 $88K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,565 $66K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,915 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 561 $65K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,142 $53K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,362 $46K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,417 $46K
72125 Computed tomography, cervical spine; without contrast material <1% 1,196 $40K
73630 <1% 1,580 $38K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 555 $37K
71250 <1% 459 $36K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,530 $32K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 27,092 $26K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,692 $24K
70498 <1% 96 $23K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 320 $23K
73030 <1% 1,345 $22K
84484 <1% 12,952 $21K
73610 <1% 1,183 $21K
80048 Basic metabolic panel (calcium, ionized) <1% 5,491 $21K
73130 <1% 875 $19K
20610 <1% 235 $19K
73564 <1% 562 $18K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 31 $17K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,180 $17K
83880 <1% 2,394 $16K
87040 <1% 2,728 $16K
72100 <1% 681 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,477 $15K
84443 Thyroid stimulating hormone (TSH) <1% 2,062 $15K
93017 <1% 120 $14K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 14 $13K
71045 Radiologic examination, chest; single view <1% 8,522 $13K
83605 <1% 9,966 $13K
73562 <1% 793 $12K
96367 <1% 272 $12K
36415 Collection of venous blood by venipuncture <1% 6,932 $12K
76642 <1% 102 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,233 $12K
87081 <1% 4,944 $10K
97162 <1% 53 $10K
73502 <1% 630 $9K
73110 <1% 410 $9K
90715 <1% 256 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,560 $7K
85379 <1% 1,559 $7K
80047 <1% 1,440 $7K
80061 Lipid panel <1% 1,091 $6K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,911 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 294 $6K
82948 <1% 2,383 $6K
74018 <1% 254 $6K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 322 $5K
81025 <1% 4,299 $5K
J3490 Unclassified drugs <1% 7,288 $5K
87632 <1% 95 $5K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 97 $5K
83735 <1% 9,791 $5K
86756 <1% 339 $5K
93971 <1% 63 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 883 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,125 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,132 $4K
82248 <1% 1,078 $3K
85027 <1% 874 $3K
84466 <1% 243 $3K
80143 <1% 543 $3K
82728 <1% 403 $3K
96376 <1% 3,106 $3K
81001 <1% 11,910 $3K
87581 <1% 97 $3K
87486 <1% 97 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 356 $2K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 58 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,997 $2K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 166 $2K
73140 <1% 115 $2K
84702 <1% 1,383 $2K
76830 Ultrasound, transvaginal <1% 14 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 6,086 $2K
73560 <1% 154 $2K
85610 <1% 2,247 $2K
83540 <1% 326 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 325 $1K
82607 <1% 143 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,568 $1K
80179 <1% 499 $1K
83690 <1% 5,954 $1K
84439 <1% 172 $1K
86140 <1% 346 $1K
83655 <1% 44 $1K
J2704 Injection, propofol, 10 mg <1% 4,176 $973.54
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,853 $970.85
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 514 $968.22
A9585 Injection, gadobutrol, 0.1 ml <1% 29 $924.12
81003 <1% 3,328 $892.48
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,855 $866.67
87077 <1% 2,290 $845.18
82553 <1% 204 $834.63
77062 <1% 31 $813.02
76942 <1% 19 $803.11
J2550 Injection, promethazine hcl, up to 50 mg <1% 478 $764.65
82947 <1% 3,104 $678.97
J7030 Infusion, normal saline solution , 1000 cc <1% 4,563 $662.94
87430 <1% 2,431 $524.22
82077 <1% 701 $501.38
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,920 $470.05
86900 <1% 465 $431.56
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 965 $418.49
72110 <1% 12 $411.70
80320 <1% 378 $366.44
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 160 $365.47
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 54 $344.37
87147 <1% 223 $344.24
84100 <1% 400 $339.63
82550 <1% 521 $315.65
84703 <1% 948 $291.59
80076 <1% 92 $285.23
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,205 $271.55
J7050 Infusion, normal saline solution, 250 cc <1% 3,130 $236.15
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,118 $233.86
74022 <1% 41 $229.68
82565 <1% 344 $228.92
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,737 $219.94
J1650 Injection, enoxaparin sodium, 10 mg <1% 720 $219.78
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 315 $218.60
86901 <1% 465 $210.32
J0690 Injection, cefazolin sodium, 500 mg <1% 697 $204.45
87186 <1% 1,211 $180.40
72070 <1% 13 $176.66
85730 <1% 798 $168.45
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 55 $165.75
A9150 Non-prescription drugs <1% 7,682 $153.88
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 30 $152.23
82746 <1% 29 $151.59
73080 <1% 13 $149.08
J1030 Injection, methylprednisolone acetate, 40 mg <1% 466 $148.40
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 678 $144.14
85014 <1% 1,455 $133.72
J1170 Injection, hydromorphone, up to 4 mg <1% 1,705 $126.81
87070 <1% 12 $123.38
82150 <1% 355 $117.65
86850 <1% 191 $117.37
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 14 $115.79
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 228 $104.64
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 451 $102.06
86885 <1% 75 $100.00
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 382 $96.80
85652 <1% 34 $92.73
87184 <1% 251 $84.61
36592 <1% 278 $82.19
82805 <1% 40 $64.28
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,669 $56.58
J2060 Injection, lorazepam, 2 mg <1% 481 $53.47
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 158 $37.69
82803 <1% 218 $33.99
87205 <1% 13 $33.08
82043 <1% 12 $30.78
87210 <1% 79 $26.27
81002 <1% 390 $24.81
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 350 $24.11
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 248 $11.18
J1815 Injection, insulin, per 5 units <1% 41 $3.30
J3480 Injection, potassium chloride, per 2 meq <1% 44 $3.12
J1630 Injection, haloperidol, up to 5 mg <1% 47 $2.38
J7510 Prednisolone oral, per 5 mg <1% 49 $2.21
J1940 Injection, furosemide, up to 20 mg <1% 24 $1.70
J0780 Injection, prochlorperazine, up to 10 mg <1% 32 $1.44
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 63 $0.21
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 118 $0.00
A9270 Non-covered item or service 0% 4,402 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 73 $0.00
94760 0% 111 $0.00
96368 0% 12 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 16 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 17 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 125 $0.00
73590 0% 18 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 34 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 18 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 195 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARLAN, ELIZABETH (REVENUE CYCLE DIRECTOR)
Same official

Other billing entities under HARLAN, ELIZABETH

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.